Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls
Open Access
- 6 January 2023
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 252, 39-45
Abstract
No abstract availableKeywords
Funding Information
- Lundbeck Foundation
This publication has 20 references indexed in Scilit:
- Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune originThe Lancet Psychiatry, 2020
- Clinically Relevant Anti-Neuronal Cell Surface Antibodies in Schizophrenia Spectrum DisordersNeuropsychobiology, 2019
- Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disordersThe British Journal of Psychiatry, 2018
- Antibody-Mediated EncephalitisNew England Journal of Medicine, 2018
- Frequencies of neuronal autoantibodies in healthy controlsNeurology Neuroimmunology & Neuroinflammation, 2017
- Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric PatientsFrontiers in Psychiatry, 2017
- Anti‐contactin‐associated protein‐2 encephalitis: relevance of antibody titres, presentation and outcomeEuropean Journal of Neurology, 2016
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysisPsychological Medicine, 2013
- Frequency and Characteristics of Isolated Psychiatric Episodes in Anti–N-Methyl-d-Aspartate Receptor EncephalitisJAMA Neurology, 2013